Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126845061 | 12684506 | 1 | I | 201604 | 20160809 | 20160824 | 20160824 | EXP | DE-IBIGEN-2016.02094 | IBI LORENZINI | 51.00 | YR | A | F | Y | 97.00000 | KG | 20160819 | CN | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126845061 | 12684506 | 1 | PS | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | Oral | 2 DOSAGES 500 MG DAILY DAILY DOSE: 1000 MG MILLGRAM EVERY DAYS | N | 0 | 500 | MG | BID | ||||||
| 126845061 | 12684506 | 2 | SS | CLINDAMYCIN | CLINDAMYCINCLINDAMYCIN PHOSPHATE | 1 | Oral | DAILY DOSE: 1800 MG MILLGRAM(S) EVERY DAYS | 14400 | MG | N | 0 | 600 | MG | TID | ||||
| 126845061 | 12684506 | 3 | SS | piperacillin/Tazobactam | PIPERACILLIN SODIUMTAZOBACTAM SODIUM | 1 | Intravenous (not otherwise specified) | 3 DOSAGES 4.5 G DAILY DAILY DOSE: 13.5 G GRAM(S) EVERY DAYS | N | 0 | 4.5 | G | TID | ||||||
| 126845061 | 12684506 | 4 | C | doxycyclin | DOXYCYCLINE | 1 | Oral | DAILY DOSE: 200 MG MILLGRAM(S) EVERY DAYS | U | 0 | 200 | MG | QD | ||||||
| 126845061 | 12684506 | 5 | C | tramal long | TRAMADOL | 1 | Oral | DAILY DOSE: 200 MG MILLGRAM(S) EVERY DAYS | 600 | MG | U | 0 | 100 | MG | BID | ||||
| 126845061 | 12684506 | 6 | C | NOVALGIN | METAMIZOLE SODIUM | 1 | Oral | DAILY DOSE: 2000 MG MILLGRAM(S) EVERY DAYS | 6000 | MG | U | 0 | 500 | MG | QID | ||||
| 126845061 | 12684506 | 7 | C | PANTOZOL | PANTOPRAZOLE SODIUM | 1 | Oral | DAILY DOSE: 40 MG MILLGRAM(S) EVERY DAYS | U | 0 | 40 | MG | QD | ||||||
| 126845061 | 12684506 | 8 | C | mono-embolex | CERTOPARIN SODIUM | 1 | Subcutaneous | DAILY DOSE: 3000 IU INTERNATIONAL UNIT(S) EVERY DAYS | 9000 | IU | U | 0 | 3000 | IU | QD | ||||
| 126845061 | 12684506 | 9 | C | CLINDAMYCIN | CLINDAMYCINCLINDAMYCIN PHOSPHATE | 1 | Oral | DAILY DOSE: 1800 MG MILLGRAM(S) EVERY DAYS | U | 0 | 600 | MG | TID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126845061 | 12684506 | 1 | Osteitis |
| 126845061 | 12684506 | 2 | Osteitis |
| 126845061 | 12684506 | 3 | Osteitis |
| 126845061 | 12684506 | 4 | Osteitis |
| 126845061 | 12684506 | 5 | Pain |
| 126845061 | 12684506 | 6 | Pain |
| 126845061 | 12684506 | 7 | Gastritis |
| 126845061 | 12684506 | 8 | Thrombosis prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126845061 | 12684506 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126845061 | 12684506 | Epicondylitis | |
| 126845061 | 12684506 | Sensory loss | |
| 126845061 | 12684506 | Tendon pain |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126845061 | 12684506 | 1 | 20160402 | 20160419 | 0 | |
| 126845061 | 12684506 | 2 | 20160325 | 20160402 | 0 | |
| 126845061 | 12684506 | 3 | 20160402 | 20160407 | 0 | |
| 126845061 | 12684506 | 4 | 20160408 | 201605 | 0 | |
| 126845061 | 12684506 | 5 | 20160330 | 20160423 | 0 | |
| 126845061 | 12684506 | 6 | 20160330 | 201605 | 0 | |
| 126845061 | 12684506 | 7 | 20160416 | 20160423 | 0 | |
| 126845061 | 12684506 | 8 | 20160330 | 201605 | 0 | |
| 126845061 | 12684506 | 9 | 20160412 | 20160419 | 0 |